Skip to main content

MARSHALL WACE, LLP

Position in IQV — Iqvia Holdings Inc.

CIK 1318757 LONDON, X0

Position in IQV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,277,824
+$7,216,430 QoQ
Shares Held
37,666
+10362.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#265
of 1,077 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IQV Over Time

Shares Held

Position Value (USD)

Derivatives in IQV

reported options exposure · as of Mar 31, 2026
CallValue
$324,026
CallShares
1,900
PutValue
$528,674
PutShares
3,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. IQV ranks #15 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IQV

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,277,824 37,666
2026-03-31 $61,394 360
2026-03-31 $528,674 3,100
2026-03-31 $324,026 1,900
2025-06-30 $55,187,859 350,199
2025-03-31 $136,945,255 776,774
2024-12-31 $187,528,313 954,294
2024-09-30 $121,955,425 514,645
2024-06-30 $16,409,858 77,610
2024-03-31 $2,942,628 11,636
2022-09-30 $75,678,299 417,789
2022-06-30 $13,519,995 62,307
2022-03-31 $42,594,431 184,224
2021-12-31 $31,732,003 112,469
2021-09-30 $5,153,703 21,515
2021-06-30 $307,988 1,271
2020-12-31 $47,006,862 262,359
2020-09-30 $47,525,760 301,502
2020-06-30 $43,990,603 310,055
2020-03-31 $67,533,303 626,120